How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
top of page
BPIQ Blog
Jul 25, 20221 min read
Biopharma Mid Morning Pulse - 07/25/22
(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 25, 20221 min read
Free Biopharma Mid Morning Pulse - 07/25/22
(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 5, 20222 min read
Biopharma Pulse - June Month in Review
As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...
Jun 24, 20223 min read
Biopharma Pulse - 6/20-6/24 Week in Review
As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 22, 20222 min read
Biopharma Daily Stock Updates - 06/22/22
$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...
Jun 22, 20222 min read
Free Biopharma Daily Stock Updates - 06/22/22
$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page